BPC-157 10mg

Description

BPC-157 10mg, with the documents needed for a careful review

Purity Collective supplies BPC-157 10mg in a lyophilized vial for qualified laboratory research. This page brings the catalog identity, listed quantity, SKU and available analytical documents into one clear record, helping procurement teams review what is actually documented before placing an order.

Analytical results should be read in context. Check the compound and lot identifiers, reported methods, dates, specifications and results across the complete documents rather than relying on a percentage or pass-style label by itself.

Product details

Available analytical documents

Review the BPC-157 10mg UPLC/MS report and the BPC-157 endotoxin report in full. If you are comparing laboratory records, the guide to reading a peptide COA explains the fields worth checking. For identity, FDA-context and product-record boundaries, read the BPC-157 research and COA guide. If you need a component-by-component comparison, review the BPC-157 + TB-500 10mg blend record separately.

The UPLC/MS report identifies BPC-157 and lists lot PCCL-9216929. For that lot, it records a measured quantity of 10.15mg against a 10mg specification and a purity result of 99.54% against a greater-than-98% specification. Those numbers describe the submitted sample and report; they are not presented as universal specifications for every unit.

The endotoxin report identifies lot PCCL-9216929-E and records a result below 0.05 EU/mL. It does not print an acceptance specification. It also displays an analysis date of April 3, 2026 and a received date of April 8, 2026, a chronology that buyers should note when evaluating the record. Neither document establishes sterility, safety, suitability or performance.

Why Purity Collective presents the full record

A useful research listing should make verification easier, not hide behind broad promises. Purity Collective pairs the product identity and format with direct document access, while clearly separating lot-specific report data from general catalog information. That gives qualified buyers a more practical basis for supplier review and internal acceptance decisions.

Before you order

• Confirm that BPC-157, the 10mg listed quantity and SKU PC-BPC-157-10MG match the procurement request.
• Review both reports, including their lot identifiers, methods, dates, specifications and results.
• Treat the numerical results as data for the reported sample, not as blanket product guarantees.
• Apply your laboratory’s own supplier-qualification, acceptance, storage and handling procedures.

BPC-157 10mg FAQs

What is listed on this BPC-157 10mg page?

This catalog page lists BPC-157 with a stated quantity of 10mg, supplied in a lyophilized vial under SKU PC-BPC-157-10MG for qualified laboratory research.

Which documents are available for this listing?

The page links to a two-page UPLC/MS report and a separate endotoxin report. Each should be reviewed as a complete document, including its compound identity, lot, dates, method, specification fields and reported results.

What does the UPLC/MS report show?

For lot PCCL-9216929, the report identifies BPC-157 and records 10.15mg measured quantity and 99.54% purity. These are lot-specific report results and do not establish sterility, safety or suitability.

What should I check when comparing BPC-157 documents?

Match the compound and lot identifiers first, then review the method, analysis and received dates, specifications and results. Note that the linked endotoxin report prints no acceptance specification and shows an analysis date earlier than its received date.

Is BPC-157 10mg intended for human use?

No. This product is supplied only for qualified laboratory research and is not for human or veterinary administration. Purity Collective does not provide clinical, therapeutic, dosing or administration guidance.

Research-use notice

For qualified laboratory research only. Not for human or veterinary administration. This listing is not presented as a medicine or treatment.